312c7d53-cee3-415c-9839-64fbd555b133 beie director@blueeyesintelligence.org 10.35940/ijitee.E9493.0412523 10.3390/pharmaceutics11060256Roohnikan M, Laszlo E, Babity S, Brambilla DA. Snapshot of transdermal and tropical drug delivery research in Canada. Pharmaceutics. 2019;11(6):256. [CrossRef]10.1007/s12247-020-09525-2Peña-Juárez MC, Guadarrama-Escobar OR, Escobar-Chávez JJ. Transdermal delivery Systems for Biomolecules. J Pharm Innov. 2021;6:1-14. [CrossRef]10.15406/mojbb.2017.03.00031Ali H. Transdermal drug delivery system & patient compliance. MOJ Bioequiv Availab. 2017;3(2):47-8. [CrossRef]10.3390/molecules23030681Leppert W, Malec-Milewska M, Zajaczkowska R, Wordliczek J. Transdermal and Topical Drug Administration in the Treatment of Pain. Molecules. 2018;23(3):681. [CrossRef]10.1515/bmt-2019-0019Akhter N, Singh V, Yusuf M, Khan RA. Non-invasive drug delivery technology: development and current status of transdermal drug delivery devices, techniques and biomedical applications. Biomed Tech. 2020;65(3):243-72. [CrossRef]10.3390/jpm9040049Pires LR, Vinayakumar KB, Turos M, Miguel V, Gaspar J. A perspective on microneedle-based drug delivery and diagnostics in Paediatrics. J Pers Med. 2019;9(4):49. [CrossRef]10.3109/03639045.2013.879720Ruby PK, Pathak SM, Aggarwal D. Critical attributes of transdermal drug delivery system (TDDS) - a generic product development review. Drug Dev Ind Pharm. 2014;40(11):1421-8. [CrossRef]Biomaterials 26Kim200510.1016/j.biomaterials.2004.05.015Delivery of a vector encoding mouse hyaluronan synthase 2 via a crosslinked hyaluronan filmKim AP, Yellen P, Yun YH, et al. (2005). Delivery of a vector encoding mouse hyaluronan synthase 2 via a crosslinked hyaluronan film. Biomaterials 26:1585-93. [CrossRef]Ko YK, Kim SH, Jeong JS, et al. (2007). Preparation and characterization of hyaluronic acid loaded PLGA scaffold by emulsion freeze-drying method. Polymer Korea 31:505-11.10.1039/c2jm31406aLee DE, Kim AY, Hong YY, et al. (2012a). Amphiphilic hyaluronic acidbased nanoparticles for tumor-specific optical/MR dual imaging. J Mater Chem 22:10444-7. [CrossRef]J Control Release 119Lee200710.1016/j.jconrel.2007.02.011Target-specific intracellular delivery of siRNA using degradable hyaluronic acid nanogelsLee H, Mok H, Lee S, et al. (2007). Target-specific intracellular delivery of siRNA using degradable hyaluronic acid nanogels. J Control Release 119:245-52. [CrossRef]10.1158/1078-0432.CCR-11-3250Lee SJ, Ghosh SC, Han HD, et al. (2012b). Metronomic activity of CD44- targeted hyaluronic acid-Paclitaxel in ovarian carcinoma, Clin Cancer Res 18:4114-21. [CrossRef]10.5958/0974-360X.2015.00019.0Ali S, Shabbir M, Shahid N. The structure of skin and transdermal drug delivery system - a review. Res J Pharm Tech. 2015;8(2):103-9. [CrossRef]10.1002/adma.202003014Wang M, Luo Y, Wang T, Wan C, Pan L, Pan S, et al. Artificial skin perception. Adv Mater. 2020;33:e2003014. [CrossRef]10.1039/D0TB00021CHutton AR, McCrudden MT, Larrañeta E, Donnelly RF. Influence of molecular weight on transdermal delivery of model macromolecules using hydrogel-forming microneedles: potential to enhance the administration of novel low molecular weight biotherapeutics. J Mater Chem B. 2020;8(19):4202-9. [CrossRef]10.1007/s11095-012-0946-7Andrews SM, Jeong EH, Prausnitz MR. Transdermal delivery of molecules is limited by full epidermis, Not Just Stratum Corneum. Pharm Res. 2013;30(4):1099-109. [CrossRef]10.1080/21691401.2018.1430695Chaulagain B, Jain A, Tiwari A, Verma A, Jain SK. Passive delivery of protein drugs through transdermal route. Artif Cells Nanomed Biotechnol. 2018;46(1):472-87. [CrossRef]10.5772/58672Uchechi O, Ogbonna J, Attama AA. Nanoparticles for dermal and transdermal drug delivery. In: Application of nanotechnology in drug delivery. Sezer AD: InTech C; 2014. p. 193-235. [CrossRef]10.1016/j.cclet.2018.10.037Zhou X, Hao Y, Yuan L, Pradhan S, Shrestha K, Pradhan O. Nano-formulations for transdermal drug delivery: a review. Chin Chem Lett. 2018;29(12):1713-24. [CrossRef]10.1080/17425247.2020.1713087Kováčik A, Kopečná M, Vávrová K. Permeation enhancers in transdermal drug delivery: benefits and limitations. Expert Opin Drug Deliv. 2020;17(2):145-55. [CrossRef]Pawar PM, Solanki KP, Mandali VA. Recent advancements in transdermal drug delivery system. Int J Pharm Clin Res. 2018;10(3):65-73.Mujoriya R, Dhamande KA. Review on transdermal drug delivery system. Res J Sci Tech. 2011;3(4):227-31.10.21474/IJAR01/7109Patel R, Patel A, Prajapati B, Shinde G, Dharamsi A. Transdermal drug delivery systems: A mini review. Int J Adv Res. 2018;6(5):891-900. [CrossRef]Kakar S, Singh R, Rani P. A review on transdermal drug delivery. Innoriginal Int J Sci. 2016;3(4):1-5.10.1007/s13346-021-00898-6Wang Y, Zeng L, Song W, Liu J. Influencing factors and drug application of iontophoresis in transdermal drug delivery: an overview of recent progress. Drug Deliv Transl Res. 2021. [CrossRef]